LGM

Logos Global Management Portfolio holdings

AUM $749M
This Quarter Return
+24.76%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
–
AUM
$724M
AUM Growth
+$724M
Cap. Flow
-$84M
Cap. Flow %
-11.6%
Top 10 Hldgs %
51.97%
Holding
60
New
17
Increased
7
Reduced
18
Closed
10

Top Buys

1
ICVX
Icosavax, Inc. Common Stock
ICVX
$21.5M
2
ACLX icon
Arcellx
ACLX
$15.8M
3
RCUS icon
Arcus Biosciences
RCUS
$15.2M
4
CYTK icon
Cytokinetics
CYTK
$13M
5
ANNX icon
Annexon
ANNX
$12.3M

Top Sells

1
IDYA icon
IDEAYA Biosciences
IDYA
$43.5M
2
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$37M
3
XENE icon
Xenon Pharmaceuticals
XENE
$24.1M
4
ASND icon
Ascendis Pharma
ASND
$16.1M
5
APLS icon
Apellis Pharmaceuticals
APLS
$15.9M

Sector Composition

1 Healthcare 99.21%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BMRN icon
26
BioMarin Pharmaceuticals
BMRN
$11.3B
$8.67M 1.18%
100,000
-50,000
-33% -$4.33M
VTYX icon
27
Ventyx Biosciences
VTYX
$183M
$8.2M 1.12%
250,000
-20,000
-7% -$656K
DAWN icon
28
Day One Biopharmaceuticals
DAWN
$768M
$7.76M 1.06%
+650,000
New +$7.76M
KRTX
29
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$7.59M 1.03%
35,000
-65,000
-65% -$14.1M
ALXO icon
30
ALX Oncology
ALXO
$55.7M
$7.51M 1.02%
1,000,000
-500,000
-33% -$3.76M
GERN icon
31
Geron
GERN
$912M
$7.06M 0.96%
2,200,000
-1,350,000
-38% -$4.33M
DCTH icon
32
Delcath Systems
DCTH
$385M
$6.87M 0.93%
+1,178,787
New +$6.87M
GRCL
33
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$6.86M 0.93%
+1,800,000
New +$6.86M
ELVN icon
34
Enliven Therapeutics
ELVN
$1.24B
$6.27M 0.85%
307,076
-94,153
-23% -$1.92M
IMTX icon
35
Immatics
IMTX
$681M
$5.77M 0.78%
+500,000
New +$5.77M
MRNS
36
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$5.7M 0.78%
+525,000
New +$5.7M
ACRS icon
37
Aclaris Therapeutics
ACRS
$221M
$5.44M 0.74%
+525,000
New +$5.44M
KURA icon
38
Kura Oncology
KURA
$726M
$5.29M 0.72%
+500,000
New +$5.29M
BBIO icon
39
BridgeBio Pharma
BBIO
$9.94B
$5.16M 0.7%
+300,000
New +$5.16M
RCKT icon
40
Rocket Pharmaceuticals
RCKT
$353M
$4.97M 0.68%
250,000
-650,000
-72% -$12.9M
VIR icon
41
Vir Biotechnology
VIR
$749M
$4.91M 0.67%
+200,000
New +$4.91M
ATXS icon
42
Astria Therapeutics
ATXS
$388M
$4.54M 0.62%
544,960
-500,000
-48% -$4.17M
TNYA icon
43
Tenaya Therapeutics
TNYA
$184M
$3.52M 0.48%
+600,000
New +$3.52M
DBVT
44
DBV Technologies
DBVT
$258M
$2.28M 0.31%
+1,200,000
New +$2.28M
VIGL
45
DELISTED
Vigil Neuroscience
VIGL
$1.77M 0.24%
188,390
– –
SYRE icon
46
Spyre Therapeutics
SYRE
$1.04B
$1.42M 0.19%
+3,142,880
New +$1.42M
IMUX icon
47
Immunic
IMUX
$79.4M
$1.06M 0.14%
421,184
– –
LIAN
48
DELISTED
LianBio American Depositary Shares
LIAN
$638K 0.09%
280,000
– –
TYRA icon
49
Tyra Biosciences
TYRA
$680M
$543K 0.07%
31,872
-55,801
-64% -$950K
NUVB.WS icon
50
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$71.4M
$11K ﹤0.01%
66,666
– –
1
2
3